What is the argument against AHZ splitting into two companies: one that focuses on developing and selling world-class Medtech and the other that focuses on curing cancer and wiping out Herpes?
I find it bizarre that AHZ is doing both: on one hand it makes profits from at least one of its medtech products, and on the other, it feeds the money-sucking biotech-hopeful side of the business.
this could be a case of where 1 + 1 = 1 and a half
split them into two and it could be 1 + 1 = 3
- Forums
- ASX - By Stock
- AHZ is 2 companies -why not split into 2?
What is the argument against AHZ splitting into two companies:...
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.30 |
Change
0.150(0.99%) |
Mkt cap ! $323.4M |
Open | High | Low | Value | Volume |
$15.35 | $15.35 | $15.00 | $92.29K | 6.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $15.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.30 | 276 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 326 | 15.300 |
1 | 176 | 15.100 |
1 | 39 | 15.040 |
1 | 1000 | 15.000 |
1 | 756 | 14.950 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 800 | 1 |
15.200 | 36 | 1 |
15.300 | 276 | 1 |
15.700 | 277 | 1 |
15.880 | 250 | 1 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online